• Dehydroabietic Acid in Adipocyte Assays

  2026-09-18

  Use Dehydroabietic acid as a controlled dual PPAR-α/γ agonist to connect receptor signaling with lipid handling and insulin-response phenotypes in adipocyte models. This workflow also shows how to pair small-molecule perturbation with adipocyte-targeted CRISPRi without conflating pharmacology with gene silencing.

• Tunable Human Intestinal Organoids for Cell-Fate Control

  2026-09-17

  Yang and colleagues developed a chemically tunable human small-intestinal organoid system that maintains strong proliferation while increasing epithelial cell diversity. The study shows how stemness enhancement, reversible fate control, and targeted Wnt, Notch, BMP, and BET-related modulation can reduce the need to separate organoid expansion from differentiation.

• Pioglitazone: PPARγ Agonist Workflow Guide

  2026-09-17

  Pioglitazone gives researchers a practical way to connect PPARγ activation with macrophage polarization, intestinal barrier integrity, and metabolic transcriptional responses. This workflow guide translates a DSS-induced inflammatory bowel disease study into assay design, formulation, controls, and troubleshooting decisions.

• Tricine-SDS-PAGE Gel Preparation Kit Guide

  2026-09-16

  The Tricine-SDS-PAGE Gel Preparation Kit is intended for resolving low-molecular-weight proteins and peptides that are poorly separated by conventional Tris-SDS-PAGE. It supports research protein electrophoresis in denaturing or non-denaturing workflows, but it is not intended for diagnostic, clinical, or medical use.

• Stable Yeast Expression of Exendin-4 for T2D

  2026-09-16

  A 2024 Frontiers in Systems Biology study established a proof of concept for producing Exendin-4 in Escherichia coli and Saccharomyces cerevisiae, with the clearest validation obtained from a chromosomally integrated yeast strain. Detection at the expected peptide size and confirmation by immunoassay support further investigation of locally propagated production, but do not yet demonstrate bioactivity, oral delivery, or therapeutic equivalence.

• Ertugliflozin, Brain Insulin Signaling, and Tau

  2026-09-15

  This study tested whether the SGLT2 inhibitor ertugliflozin could reduce cognitive and molecular abnormalities in a streptozotocin-induced rat model of brain insulin resistance. Its main contribution is linking improved behavioral performance with reduced tau hyperphosphorylation, altered IRS-1/Akt/GSK3β signaling, and protection of cholinergic, mitochondrial, apoptotic, and synaptic endpoints.

• Guanabenz Acetate for GPCR Assays

  2026-09-15

  Guanabenz Acetate provides a practical way to interrogate α2-adrenergic signaling alongside stress-response and innate-immunity readouts. This workflow-focused guide covers DMSO preparation, subtype-aware dosing, atypical stress-granule assays, and troubleshooting without overstating evidence from antiviral models.

• Aclacinomycin A DNA Damage Workflow

  2026-09-14

  Aclacinomycin A, also known as Aclarubicin, combines topoisomerase-driven DNA damage with apoptosis and proteasome biology, making it useful for mechanistic cancer assays. This workflow translates persistent ribosomal DNA lesion research into practical dose, imaging, repair-response, and troubleshooting strategies.

• 6-Thioguanine Restricts EV71 by Reducing Autophagy

  2026-09-14

  A 2025 BMC Microbiology study identifies 6-thioguanine as an in vitro inhibitor of Enterovirus 71 replication and links its activity to reduced BIRC3-mediated autophagy. The work combines antiviral efficacy, cytotoxicity, viral-progeny measurements, and pathway analysis to define a potential host-directed strategy that still requires validation beyond HT-29 cell cultures.

• Dehydroabietic Acid: PPAR Signaling & Ferroptosis

  2026-09-13

  Dehydroabietic acid is a dual PPAR-α/γ agonist for dissecting lipid metabolism, insulin signaling, and redox-sensitive phenotypes. This article connects receptor pharmacology with the WTAP–GLS ferroptosis mechanism while defining practical assay boundaries and interpretation safeguards.

• ARCA Cy5 EGFP mRNA (5-moUTP) Workflow Guide

  2026-09-12

  ARCA Cy5 EGFP mRNA (5-moUTP) separates delivery from productive translation by combining covalent Cy5 tracking with EGFP expression. This practical guide shows how to benchmark mRNA transfection in mammalian cells, compare delivery systems, and troubleshoot discordant uptake and translation signals.

• Hexamethonium Bromide and Autonomic Causality

  2026-09-11

  Hexamethonium Bromide is a selective antagonist of neuronal-type nicotinic AChR that can function as a causal probe of autonomic control. This article explains how to interpret ganglionic blockade in sex-sensitive angiotensin II hypertension research without confusing pathway contribution with receptor localization.

• Sulfisomidine in Enzyme Kinetics and Microbial Research

  2026-09-11

  Sulfisomidine, also known as sulfamethin, connects bacterial folate-pathway experiments with mechanistic human serum paraoxonase 1 inhibition studies. This guide presents practical preparation, assay design, cross-domain controls, and troubleshooting strategies for reliable enzyme and microbial workflows.

• Tolazoline for α2-Adrenergic Receptor Assays

  2026-09-10

  Tolazoline supports complementary receptor-binding, airway smooth muscle, and islet experiments, but its concentration-dependent ATP-sensitive potassium channel activity makes assay design especially important. This guide translates a part-coated capillary electrochromatography strategy into practical workflows for separating α2-adrenergic receptor antagonism from downstream functional effects.

• Breast Cancer Dependence on MCL-1 and Apoptosis

  2026-09-10

  The reference study shows that established breast tumors rely on MCL-1 primarily through its canonical anti-apoptotic activity, rather than through separable non-apoptotic functions. By combining genetic deletion, pharmacological inhibition, and BAX/BAK epistasis, the authors connect MCL-1 blockade to mitochondrial apoptosis and define a practical framework for studying cancer cell survival regulation.

8720 records 4/582 page Previous Next 12345 下5页 Last page